These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

740 related articles for article (PubMed ID: 27903462)

  • 21. The Value of CBCT-based Tumor Density and Volume Variations in Prediction of Early Response to Chemoradiation Therapy in Advanced NSCLC.
    Wen Q; Zhu J; Meng X; Ma C; Bai T; Sun X; Yu J
    Sci Rep; 2017 Nov; 7(1):14650. PubMed ID: 29116100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
    Huynh E; Coroller TP; Narayan V; Agrawal V; Romano J; Franco I; Parmar C; Hou Y; Mak RH; Aerts HJ
    PLoS One; 2017; 12(1):e0169172. PubMed ID: 28046060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: the prognostic importance of the area of residual tumor.
    Yamane Y; Ishii G; Goto K; Kojima M; Nakao M; Shimada Y; Nishiwaki Y; Nagai K; Kohrogi H; Ochiai A
    J Thorac Oncol; 2010 Jan; 5(1):49-55. PubMed ID: 20035185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
    Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
    PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomics for Classification of Lung Cancer Histological Subtypes Based on Nonenhanced Computed Tomography.
    E L; Lu L; Li L; Yang H; Schwartz LH; Zhao B
    Acad Radiol; 2019 Sep; 26(9):1245-1252. PubMed ID: 30502076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.
    Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW
    J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
    Park SH; Cheon H; Chong GO; Jeong SY; Lee JE; Kang MK; Kim MY; Lee JW; Park J; Kim JC
    Gynecol Oncol; 2018 Mar; 148(3):449-455. PubMed ID: 29329882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound-based radiomics machine learning models for diagnosing cervical lymph node metastasis in patients with non-small cell lung cancer: a multicentre study.
    Deng Z; Liu X; Wu R; Yan H; Gou L; Hu W; Wan J; Song C; Chen J; Ma D; Zhou H; Tian D
    BMC Cancer; 2024 Apr; 24(1):536. PubMed ID: 38678211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
    Konishi J; Yamazaki K; Tsukamoto E; Tamaki N; Onodera Y; Otake T; Morikawa T; Kinoshita I; Dosaka-Akita H; Nishimura M
    Respiration; 2003; 70(5):500-6. PubMed ID: 14665776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.
    Zhang N; Liang R; Gensheimer MF; Guo M; Zhu H; Yu J; Diehn M; Loo BW; Li R; Wu J
    Theranostics; 2020; 10(25):11707-11718. PubMed ID: 33052242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive classification of non-small cell lung cancer: a comparison between random forest models utilising radiomic and semantic features.
    Bashir U; Kawa B; Siddique M; Mak SM; Nair A; Mclean E; Bille A; Goh V; Cook G
    Br J Radiol; 2019 Jul; 92(1099):20190159. PubMed ID: 31166787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.
    Park SY; Yoon JK; Park KJ; Lee SJ
    Cancer Imaging; 2015 Dec; 15():21. PubMed ID: 26694918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis.
    Luo X; Zang X; Yang L; Huang J; Liang F; Rodriguez-Canales J; Wistuba II; Gazdar A; Xie Y; Xiao G
    J Thorac Oncol; 2017 Mar; 12(3):501-509. PubMed ID: 27826035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
    Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
    Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of Histological Types and Stages in Non-small Cell Lung Cancer Using Radiomic Features Based on CT Images.
    Lin J; Yu Y; Zhang X; Wang Z; Li S
    J Digit Imaging; 2023 Jun; 36(3):1029-1037. PubMed ID: 36828962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.